Navigation Links
The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs
Date:3/26/2009

WELLINGTON, Fla., March 26 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (www.QuantumMD.com) announced that it has hired RedChip Companies Inc. to enhance its investor relations outreach efforts.

"We selected RedChip based on their long-history of success in broadening visibility for emerging growth companies as well as for their expertise in market positioning and their comprehensive platform of media services," said Noel J. Guillama, Chief Executive Officer of The Quantum Group.

"We're confident that RedChip will help us introduce our story to an expanded audience and in turn foster solid and lasting relationships with new stakeholders. We look forward to working with their dedicated team."

"We are very pleased with the opportunity to represent The Quantum Group," said Dave Gentry, President of RedChip Companies. He added: "With healthcare costs on the rise and the trend toward electronic medical records, I believe that Quantum's one-stop approach to provide technology solutions and services to the $2.4 trillion U.S. healthcare industry is positioning them for dramatic growth, as shown by their performance over the last 24 months. Their web-based, healthcare technology system that allows physicians, patients and providers communicate in real-time addresses a huge market need at the right time. We look forward to leveraging a comprehensive investor relations program and introducing The Quantum Group to RedChip's investor network."

RedChip joins PR Financial Marketing in investor relations activities for The Quantum Group, Inc.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization (HSO) that provides business process solutions, service chain management, strategic consulting and leading-edge technology to the healthcare industry.

Quantum has developed and deployed PWeR(TM), a cutting-edge, patent-pending healthcare technology platform that has been designed to bridge the gaps of communication and exchange of patient information throughout the healthcare industry. PWeR can integrate all of the functions a physician/provider, hospital, clinic and related professionals utilize in one patient-centric, web-based platform and falls well within the economic incentives offered by the new $19 billion Stimulus Package for healthcare information technology. We believe we are positioned to be a catalyst for change as we take aim at the $700 billion inefficiency gap in the United States healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" "could" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to continue revenue growth trend in fiscal year 2009, to control patient medical cost relative to income received, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. We have further risk in the deployment of our technology platform, the utilization by our clients, technical and software setbacks, cost of development, as well as the capital to deploy it. We are subject further to interruptions of service. Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

    FOR MORE INFORMATION, PLEASE CONTACT:
    RedChip Companies
    Dave Gentry: 407-644-4256, Ext. 104
    info@redchip.com
    or
    PR Financial Marketing
    Jim Blackman: 713-256-0369
    jim@prfmonline.com
    or
    The Quantum Group, Inc.
    Danielle Amodio:  561.798.9800
    DAmodio@QuantumMD.com


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum light beams good for fast technology
2. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
3. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
4. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
5. Results promising for computational quantum chemical methods for drug development
6. The Quantum Group, Inc. Announces Separation of Units
7. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
8. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
9. The Quantum Group Announces Strategic Technology Alliance
10. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
11. The Quantum Group Extends CEOs Employment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... “The Angel”: a heartwarming and earnest tale of faith ... his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former ... impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ was ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches ... Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted woman of faith. ... a book has been in the back of my mind for years, but actually doing ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib ... system for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, ... education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management ...
(Date:1/19/2017)... ... 19, 2017 , ... LabRoots , the leading provider ... world, announces the launch of its newly redesigned website. The sleek new design ... and trending news, vital information on upcoming virtual events and webinars, all while ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery solutions to ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Germany Cataract Surgery ... new report, "Germany Cataract Surgery Devices Market Outlook to ... Surgery Devices market. The report provides value, in millions ... (USD) within market segements - Phacoemulsification Equipment and Ophthalmic ... shares and distribution shares data for each of these ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
(Date:1/19/2017)... 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, ... The global anti-obesity drugs market is expected to grow ... forecast period and CAGR of 38.7% in the second half of ... CAGR of 32.8% from 2016 to 2027. The market is estimated ... million in 2027. ...
Breaking Medicine Technology: